Library / Laws / 119th Congress / Senate Bills / S. 1818
S. 1818
To significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2025-05-20 | 19.3K | ⠃⠗⠋ |